Document is current
Any future updates will be listed below
-
Authors
Teixeira, J. Pedro http://orcid.org/0000-0002-2466-9644
Perez Ingles, David
Barton, Jordan B.
Dean, James T.
Garcia, Pablo
Kunkel, Susan J.
Sarangarm, Preeyaporn
Weiss, Natalie K.
Schaich, Christopher L.
Busse, Laurence W.
Nielsen, Nathan D.
-
Funding
Funding for this research was provided by:
La Jolla Pharmaceutical Company
- License Information
-
More Information
Article History
Received: 16 July 2023
Accepted: 20 February 2024
First Online: 12 March 2024
Declarations
:
: The protocol was approved by the UNM Health Sciences Center Human Research Protections Office (protocol #22–111, initial approval April 27, 2022; most recent version 2.3 approved July 17, 2023) and is posted on ClinicalTrials.gov (NCT05824767). Subjects will be enrolled in this study only after written informed consent is obtained from the subject or their legal authorized representative. See supplementary material InternalRef removed for the full approved consent form.
: Not applicable.
: The authors declare that they have no competing interests.
